| Name | 1-benzyl-3-(4-methoxyphenyl)piperidin-3-ol |
|---|---|
| Synonyms |
1-benzyl-3-(4-methoxy-phenyl)-piperidin-3-ol
1-Benzyl-3-(4-methoxyphenyl)-3-piperidinol 3-Piperidinol, 3-(4-methoxyphenyl)-1-(phenylmethyl)- 3-(4-methoxyphenyl)-1-(phenylmethyl)piperidin-3-ol 3-(4-methoxyphenyl)-1-benzyl-3-piperidinol 3-(4-methoxyphenyl)-1-(phenylmethyl)-3-piperidinol |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 441.1±45.0 °C at 760 mmHg |
| Molecular Formula | C19H23NO2 |
| Molecular Weight | 297.391 |
| Flash Point | 220.6±28.7 °C |
| Exact Mass | 297.172882 |
| PSA | 32.70000 |
| LogP | 3.02 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.597 |
|
~%
946159-38-2 |
| Literature: IRM LLC; NOVARTIS AG Patent: US2009/62260 A1, 2009 ; Location in patent: Page/Page column 6 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |